Gene · 9020
Papers3,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyanine Dye Conjugation Enhances Crizotinib Localization to Intracranial Tumors, Attenuating NF-κB-Inducing Kinase Activity and Glioma Progression. | Mol Pharm | 2023 | 37939020 | PubTator, text mining | PubMed |
| Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency. | Nature | 2023 | 37938781 | PubTator, text mining | PubMed |
| Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer. | J Immunother Cancer | 2023 | 37935567 | PubTator, text mining | PubMed |
| Effects of different signaling pathways on odontogenic differentiation of dental pulp stem cells: a review. | Front Physiol | 2023 | 37929208 | PubTator, text mining | PubMed |
| IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy. | Front Immunol | 2023 | 37928523 | PubTator, text mining | PubMed |
| Pathogenesis and therapeutic implications of EBV-associated epithelial cancers. | Front Oncol | 2023 | 37901329 | PubTator, text mining | PubMed |
| Editorial: Research progress on immune microenvironment and molecular mechanism of glioma. | Front Oncol | 2023 | 37901320 | PubTator, text mining | PubMed |
| Expression signature of ten small nuclear RNAs serves as novel biomarker for prognosis prediction of acute myeloid leukemia. | Sci Rep | 2023 | 37898705 | PubTator, text mining | PubMed |
| Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression. | Genes (Basel) | 2023 | 37895302 | PubTator, text mining | PubMed |
| Evaluation of Liftover Tools for the Conversion of Genome Reference Consortium Human Build 37 to Build 38 Using ClinVar Variants. | Genes (Basel) | 2023 | 37895222 | PubTator, text mining | PubMed |
| Investigating the Molecular Mechanisms Underlying Early Response to Inflammation and Helicobacter pylori Infection in Human Gastric Epithelial Cells. | Int J Mol Sci | 2023 | 37894827 | PubTator, text mining | PubMed |
| Redox-Mediated Rewiring of Signalling Pathways: The Role of a Cellular Clock in Brain Health and Disease. | Antioxidants (Basel) | 2023 | 37891951 | PubTator, text mining | PubMed |
| Systematic P2Y receptor survey identifies P2Y11 as modulator of immune responses and virus replication in macrophages. | EMBO J | 2023 | 37881155 | PubTator, text mining | PubMed |
| Comprehensive analysis of integrin αvβ3/α6β1 in prognosis and immune escape of prostate cancer. | Aging (Albany NY) | 2023 | 37862114 | PubTator, text mining | PubMed |
| Molecular genetic aberrations in the pathogenesis of multiple myeloma. | Asian Biomed (Res Rev News) | 2023 | 37860676 | PubTator, text mining | PubMed |
| Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms. | Front Endocrinol (Lausanne) | 2023 | 37859992 | PubTator, text mining | PubMed |
| Role of NF-κB pathway in kidney renal clear cell carcinoma and its potential therapeutic implications. | Aging (Albany NY) | 2023 | 37847185 | PubTator, text mining | PubMed |
| Methylomics and cancer: the current state of methylation profiling and marker development for clinical care. | Cancer Cell Int | 2023 | 37840147 | PubTator, text mining | PubMed |
| Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling. | Cancers (Basel) | 2023 | 37835430 | PubTator, text mining | PubMed |
| The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review. | Cancers (Basel) | 2023 | 37835380 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9020/papers?page=10